Shanghai Kinetic Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 09:29 am EDT
Share
Shanghai Kinetic Medical Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 317.55 million compared to CNY 305.65 million a year ago. Revenue was CNY 317.55 million compared to CNY 305.65 million a year ago. Net income was CNY 75.49 million compared to CNY 54.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.1048 compared to CNY 0.0756 a year ago. Diluted earnings per share from continuing operations was CNY 0.1048 compared to CNY 0.0756 a year ago.
Shanghai Kinetic Medical Co., Ltd is a China-based company principally engaged in the research, development, manufacture and sale of minimally invasive surgical systems. The Company is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The Company operates its business in domestic market.